Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer



Status:Active, not recruiting
Conditions:Breast Cancer, Cancer, Postmenopausal Syndrome, Women's Studies
Therapuetic Areas:Endocrinology, Oncology, Reproductive
Healthy:No
Age Range:18 - Any
Updated:3/29/2019
Start Date:May 15, 2008

Use our guide to learn which trials are right for you!

Endocrine Therapy With or Without Anti-VEGF Therapy: A Randomized, Phase III Trial of Endocrine Therapy Alone or Endocrine Therapy Plus Bevacizumab (NSC 704865) for Women With Hormone Receptor-Positive Advanced Breast Cancer

This randomized phase III trial studies tamoxifen citrate or letrozole together with
bevacizumab to see how well it works compared with tamoxifen citrate or letrozole alone in
treating women with stage IIIB or stage IV breast cancer. Estrogen can cause the growth of
breast cancer cells. Hormone therapy using tamoxifen citrate or letrozole may fight breast
cancer by blocking the use of estrogen by the tumor cells. Immunotherapy with monoclonal
antibodies, such as bevacizumab, may induce changes in the body's immune system and may
interfere with the ability of tumor cells to grow and spread. It is not yet known whether
giving hormone therapy is more effective with or without bevacizumab in treating advanced
breast cancer.

PRIMARY OBJECTIVES:

I. To compare the progression-free survival of letrozole therapy alone with the combination
of letrozole therapy plus bevacizumab as first-line treatment in women with estrogen- and/or
progesterone-receptor-positive advanced breast cancer.

SECONDARY OBJECTIVES:

I. To compare the proportion of patients receiving letrozole alone, who remain
progression-free at 6 and 12 months, to those receiving letrozole plus bevacizumab.

II. To compare the incidence of objective response (complete response [CR] + partial response
[PR]) in patients receiving letrozole with and without bevacizumab, as determined by Response
Evaluation Criteria in Solid Tumors (RECIST) criteria, excluding patients with non-measurable
disease.

III. To compare the incidence of clinical benefit (CR + PR + stable disease >= 6 months) in
patients receiving letrozole with and without bevacizumab.

IV. To compare the duration of objective response in patients receiving letrozole with and
without bevacizumab.

V. To compare the time to treatment failure in patients receiving letrozole with and without
bevacizumab.

VI. To compare the overall survival of patients receiving letrozole with and without
bevacizumab, including the probability of survival until 36 months.

VII. To compare toxicity levels between the bevacizumab arm and the arm without bevacizumab
in both the letrozole-treated patients and in the tamoxifen-treated patients.

VIII. To compare progression-free survival and overall survival of all patients receiving
endocrine therapy with and without bevacizumab (by combining both letrozole and tamoxifen*
patient subgroups).

CORRELATIVE OBJECTIVES:

I. To compare baseline and changes in serial levels of circulating endothelial cells and
circulating tumor cells in patients treated with endocrine therapy alone or endocrine therapy
plus bevacizumab, and to explore the relationship of these markers with progression free
survival.

II. To conduct proteomic analysis of longitudinal samples from patients with advanced-stage
disease undergoing hormonal therapy to define new serum-based biomarkers related to disease
activity.

III. To identify biologic correlates that will predict progression-free survival (PFS) and
response to therapy.

IV. To conduct pharmacogenomic assessment of candidate variants in the VEGF, CYP2D6, and
CYP19 genes and evaluate their association with PFS and other study outcomes.

V. To identify single nucleotide polymorphisms (SNPs) associated with progression free
survival in the genome-wide approach (GWAS).

VI. To identify factors other than chronological age that predict the risk of grade 3, 4 or 5
toxicity with bevacizumab and endocrine therapy by means of functional age assessment
measures.

VII. To perform an exploratory analysis of the ability of the other factors included in the
functional age assessment (either individual or in combination), to predict the risk of grade
3, 4 or 5 toxicity.

VIII. To evaluate longitudinal changes in the parameters of the factors described in
objective VI while on therapy.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

NOTE: The placebo-controlled portion of the study was canceled on 5-15-10.

ARM I: Patients receive endocrine therapy* (tamoxifen citrate or letrozole) orally (PO) once
daily (QD) on days 1-21 and bevacizumab intravenously (IV) over 30-90 minutes on day 1.
Treatment repeats every 21 days in the absence of disease progression or unacceptable
toxicity.

ARM II: Patients receive endocrine therapy* (tamoxifen citrate or letrozole) PO QD on days
1-21. Treatment repeats every 21 days in the absence of disease progression or unacceptable
toxicity.

After completion of study therapy, patients are followed up every 6 months for the first 2
years and then annually for up to 3 years.

* NOTE: As of 5/15/2011, patients only receive letrozole.

Inclusion Criteria:

- Histologic confirmation of invasive cancer of the female breast in either the primary
or metastatic setting

- Stage IV disease or stage IIIB disease (using American Joint Committee on Cancer
[AJCC] criteria, 6th edition) not amenable to local therapy

- Patients may not have a "currently active" second malignancy other than non-melanoma
skin cancers; patients are not considered to have a "currently active" malignancy if
they have completed therapy and are considered by their physician to be at less than
30% risk of relapse

- Tumors (from either primary or metastatic sites) must express estrogen receptor (ER)
and/or progesterone receptor (PgR) in >= 1% of cells will be considered positive

- Postmenopausal women are eligible for this trial; before study registration,
menopausal status must be defined according to the criteria below:

- Age >= 55 years and one year or more of amenorrhea

- Age < 55 years and one year or more of amenorrhea, with an estradiol assay < 20
pg/ml

- For women age < 55 with prior hysterectomy but intact ovaries, with an estradiol
assay < 20 pg/ml

- Surgical menopause with bilateral oophorectomy (at least 28 days must elapse from
surgery to time of study registration)

- Ovarian suppression on a luteinizing hormone-releasing hormone (LH-RH) agonist

- Premenopausal women who do not meet the postmenopausal criteria above are also
eligible, but are required to undergo ovarian suppression; this can be initiated any
time prior to or on day 1 of protocol therapy, regardless of chosen endocrine therapy,
and will continue for the duration of protocol therapy

- Patients must have measurable or non-measurable disease by RECIST criteria, with
radiologic scans within 28 days of study registration

- Measurable disease: lesions that can be accurately measured in at least one
dimension (longest diameter to be recorded) as >= 2.0 cm with conventional
techniques or as >= 1.0 cm with spiral computed tomography (CT) scan

- Non-measurable disease: all other lesions, including small lesions (longest
diameter < 2.0 cm with conventional techniques or < 1.0 cm with spiral CT scan)
and truly non-measurable lesions

- Lesions that are considered non-measurable include the following:

- Bone lesions

- Leptomeningeal disease

- Ascites

- Pleural/pericardial effusion

- Inflammatory breast disease

- Abdominal masses that are not confirmed and followed by imaging techniques

- Cystic lesions

- Prior endocrine therapy is not required

- Prior endocrine therapy in the metastatic setting is not permitted (unless
tamoxifen or an aromatase inhibitor was initiated within 4 weeks prior to
registration to facilitate enrollment of patients who recently started first-line
endocrine therapy for metastatic breast cancer); if prior letrozole therapy was
initiated within the past 4 weeks, the patients should remain on letrozole as the
study therapy; patients who began therapy with tamoxifen, anastrozole or
exemestane must switch to letrozole to be eligible to participate in this study

- Prior endocrine therapy in the adjuvant setting is permitted; there is no time
restriction for how long the patient must be on the adjuvant endocrine therapy,
nor is there a time restriction for how long the patient needs to be off prior
adjuvant endocrine therapy before beginning protocol therapy on 40503

- Prior treatment with ovarian suppression is allowed in either the adjuvant or
metastatic setting; if medical ovarian suppression is being administered it can
be initiated any time prior to or at the start of protocol therapy, and continued
throughout the duration of the trial; surgical castration with bilateral
oophorectomy must be performed at least 28 days prior to study registration (due
to concerns of poor wound healing on bevacizumab)

- Patients may not have received any prior anti-VEGF or VEGFR tyrosine kinase inhibitor
therapy

- Prior radiotherapy must have been completed and all toxicities resolved at least two
weeks prior to registration

- Chemotherapy in the adjuvant or neoadjuvant setting is permitted; at least twelve
months prior to registration must have elapsed since the completion of adjuvant or
neoadjuvant chemotherapy and all toxicities must have resolved; taxane-related
neurotoxicity must have resolved to sensory grade < 2 and no motor neuropathy of any
grade is allowed

- Patients may have received one prior chemotherapy regimen for metastatic disease; the
final dose of prior chemotherapy must have been administered at least 3 weeks prior to
study registration

- Treatment with bisphosphonates is allowed and recommended as per American Society of
Clinical Oncology (ASCO) guidelines

- Patients must not have had a major surgical procedure, open biopsy, or significant
traumatic injury within 28 days prior to study registration, and must have fully
recovered from any such procedure

- Patients must not have anticipation of need for major surgical procedure during the
course of the study

- Patients must not have had a core biopsy or other minor surgical procedure, within 7
days prior to study registration; placement of a vascular access device is allowed
within 7 days of registration

- Patients must not have a history of abdominal fistula, or intra-abdominal abscess
within 6 months prior to study registration

- Patients with a history of gastrointestinal (GI) perforation within 12 months prior to
registration are not eligible

- Patients with a history of significant bleeding episodes (e.g., hemoptysis, upper or
lower GI bleeding) within 6 months prior to registration are not eligible

- Patients must not have clinically significant cardiovascular disease that includes the
following:

- Uncontrolled hypertension defined as systolic blood pressure > 150 and/or
diastolic blood pressure > 90 mmHg on antihypertensive medications or any prior
history of hypertensive crisis or hypertensive encephalopathy

- History of myocardial infarction or unstable angina within past 6 months

- New York Heart Association (NYHA) grade 2 or greater congestive heart failure

- Symptomatic peripheral vascular disease

- Significant vascular disease (e.g., aortic aneurysm, aortic dissection) or
arterial thrombotic events

- Full dose anticoagulation therapy is allowed for the treatment of prior conditions
such as venous thrombosis or atrial fibrillation, but not for the treatment of prior
arterial thrombotic events; patients on full dose anticoagulants must be on a stable
dose of warfarin and have an in-range international normalized ratio (INR) (usually
between 2 and 3) or be on a stable dose of low-molecular weight (LMW) heparin;
patients receiving antiplatelet agents are eligible, as are patients on daily
prophylactic aspirin or anticoagulation for atrial fibrillation

- Patients may not have a history of stroke or transient ischemic attack within 6 months
prior to study registration

- Patients with a history of seizures must be well controlled with standard medication

- Patients must not have known central nervous system (CNS) metastases or leptomeningeal
disease (screening with brain imaging is not required for asymptomatic patients)

- In aromatase inhibitor (AI)-treated patients: no known allergies to imidazole drugs,
(e.g. clotrimazole, ketoconazole, miconazole, econazole, sulconazole, tioconazole, or
terconazole) or compounds structurally similar to bevacizumab

- In tamoxifen treated patients: no known allergies to selective estrogen receptor
modulators (e.g. tamoxifen, raloxifene or toremifene) or compounds structurally
similar to bevacizumab; for patients enrolled after Update #5, endocrine therapy will
consist of letrozole only and this criterion will no longer apply

- Eastern Cooperative Oncology Group (ECOG) (Zubrod) performance status =< 1

- No serious, non-healing wound, ulcer, or bone fracture

- Life expectancy of >= 12 weeks

- All patients who are premenopausal (if not already receiving ovarian suppression
therapy/surgical oophorectomy) must have a negative beta-human chorionic gonadotropin
(beta-Hcg) prior to starting on study treatment; patients may not be pregnant or
nursing at any time during the study; ovarian suppression is required in women of
childbearing potential by the start of protocol therapy, and will continue for the
duration of protocol therapy

- Granulocytes >= 1,000/ul

- Platelet count >= 100,000/ul

- Creatinine =< 2.0 mg/dL

- Bilirubin =< 1.5 times upper limit of normal (ULN) unless due to Gilbert's syndrome

- Transaminases (alanine aminotransferase [ALT], aspartate aminotransferase [AST]) =<
2.5 times ULN

- International normalized ratio (INR) =< 1.6, unless on full dose warfarin

- Beta-Hcg negative in premenopausal women

- Urine protein =< 1+ or urine to plasma creatinine (UPC) < 1

- Patients discovered to have >= 2+ proteinuria at baseline must undergo a 24-hour
urine collection that must demonstrate < 1 g of protein/24 hr, or UPC ratio < 1
to allow participation in the study
We found this trial at
528
sites
615 N Michigan Street
South Bend, Indiana 46601
(574) 647-7370
Northern Indiana Cancer Research Consortium The Northern Indiana Cancer Research Consortium (NICRC) is comprised of...
?
mi
from
South Bend, IN
Click here to add this to my saved trials
361 Old Belgrade Road
Augusta, Maine 04330
(207) 621-6100
Harold Alfond Center for Cancer Care MaineGeneral's Harold Alfond Center for Cancer Care (HACCC) is...
?
mi
from
Augusta, ME
Click here to add this to my saved trials
75 Francis street
Boston, Massachusetts 02115
(617) 732-5500
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
?
mi
from
Boston, MA
Click here to add this to my saved trials
330 Brookline Ave
Boston, Massachusetts 02215
617-667-7000
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
?
mi
from
Boston, MA
Click here to add this to my saved trials
1 Hurley Plaza
Flint, Michigan 48503
(810) 262-9000
Hurley Medical Center From its founding in 1908, Hurley Medical Center has devoted itself to...
?
mi
from
Flint, MI
Click here to add this to my saved trials
4725 North Federal Highway
Fort Lauderdale, Florida 33308
(954) 771-8000
Holy Cross Hospital While spirituality plays an essential role in the way that we minister...
?
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
2500 N State St
Jackson, Mississippi 39216
(601) 984-1000
University of Mississippi Medical Center The University of Mississippi Medical Center, located in Jackson, is...
?
mi
from
Jackson, MS
Click here to add this to my saved trials
Jupiter, Florida 33458
?
mi
from
Jupiter, FL
Click here to add this to my saved trials
524 South Park Street
Kalamazoo, Michigan 49007
(269) 341-7654
Bronson Methodist Hospital Our healthcare system serves patients and families throughout southwest Michigan and northern...
?
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
200 North Park Street
Kalamazoo, Michigan 49007
(269) 382-2500
West Michigan Cancer Center In 1994, Borgess Health Alliance and Bronson Healthcare Group opened the...
?
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
777 Hemlock Street
Macon, Georgia 31201
(478) 633-1000
Medical Center of Central Georgia Navicent Health is a designated Level I Trauma Center and...
?
mi
from
Macon, GA
Click here to add this to my saved trials
4805 Northeast Glisan Street
Portland, Oregon 97213
(503) 215-1111
Providence Portland Medical Center We strive to give those we serve exceptional, compassionate health care...
?
mi
from
Portland, OR
Click here to add this to my saved trials
60 Crittenden Blvd # 70
Rochester, New York 14642
(585) 275-2121
University of Rochester The University of Rochester is one of the country's top-tier research universities....
?
mi
from
Rochester, NY
Click here to add this to my saved trials
3900 W Avera Drive
Sioux Falls, South Dakota 57108
(605) 322-4700
Avera Cancer Institute Avera, the health ministry of the Benedictine and Presentation Sisters, is a...
?
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
98-1079 Moanalua Road
'Aiea, Hawaii 96701
?
mi
from
'Aiea, HI
Click here to add this to my saved trials
Aberdeen, South Dakota 57401
?
mi
from
Aberdeen, SD
Click here to add this to my saved trials
1200 Old York Road
Abington, Pennsylvania 19001
(215) 481–2000
Abington Memorial Hospital Abington Memorial Hospital (AMH) is a 665-bed, regional referral center and teaching...
?
mi
from
Abington, PA
Click here to add this to my saved trials
Alexandria, Minnesota 56308
?
mi
from
Alexandria, MN
Click here to add this to my saved trials
Allentown, Pennsylvania 18103
?
mi
from
Allentown, PA
Click here to add this to my saved trials
Alton, Illinois 62002
?
mi
from
Alton, IL
Click here to add this to my saved trials
Ames, Iowa 50010
?
mi
from
Ames, IA
Click here to add this to my saved trials
Anderson, South Carolina 29621
?
mi
from
Anderson, SC
Click here to add this to my saved trials
2000 E Greenville St
Anderson, South Carolina 29621
(864) 512-4640
AnMedical Health Cancer Center Cancer is the general term for a group of more than...
?
mi
from
Anderson, SC
Click here to add this to my saved trials
5301 McAuley Drive
Ann Arbor, Michigan 48197
734-712-3456
Saint Joseph Mercy Hospital St. Joseph Mercy Ann Arbor Hospital is a 537-bed teaching hospital...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Ann Arbor, Michigan 48106
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Antigo, Wisconsin 54409
?
mi
from
Antigo, WI
Click here to add this to my saved trials
?
mi
from
Antioch, CA
Click here to add this to my saved trials
364 White Oak St
Asheboro, North Carolina 27203
(336) 625-5151
Randolph Hospital Since 1932, Randolph Hospital has been fortunate to employ dedicated and loyal personnel...
?
mi
from
Asheboro, NC
Click here to add this to my saved trials
Ashland, Kentucky 41101
?
mi
from
Ashland, KY
Click here to add this to my saved trials
?
mi
from
Athens, GA
Click here to add this to my saved trials
1968 Peachtree Rd NW
Atlanta, Georgia 30309
(404) 605-5000
Piedmont Hospital For more than a century, Piedmont Healthcare has been a recognized leader in...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Atlanta, Georgia 30342
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
1000 Johnson Ferry Rd NE
Atlanta, Georgia 30342
(404) 851-8000
Northside Hospital Northside Hospital-Atlanta (in Sandy Springs) opened in 1970. The original facility had 250...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Atlanta, Georgia 30342
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Augusta, Georgia 30912
?
mi
from
Augusta, GA
Click here to add this to my saved trials
1501 S Potomac St
Aurora, Colorado 80012
(303) 695-2600
Medical Center of Aurora At The Medical Center of Aurora and Centennial Medical Plaza patients...
?
mi
from
Aurora, CO
Click here to add this to my saved trials
2000 Ogden Ave
Aurora, Illinois 60504
(630) 978-6200
Rush - Copley Medical Center Rush-Copley is proud to be the leading provider of health...
?
mi
from
Aurora, IL
Click here to add this to my saved trials
Austell, Georgia 30106
?
mi
from
Austell, GA
Click here to add this to my saved trials
2401 W Belvedere Ave
Baltimore, Maryland 21215
(410) 601-9000
Sinai Hospital of Baltimore Sinai Hospital of Baltimore provides a broad array of high-quality, cost-effective...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
6701 N Charles St
Baltimore, Maryland 21204
(443) 849-2000
Greater Baltimore Medical Center The 255-bed medical center (acute and sub-acute care) is located on...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
22 South Greene Street
Baltimore, Maryland 21201
410-328-7904
University of Maryland Greenebaum Cancer Center The University of Maryland Marlene and Stewart Greenebaum Cancer...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
489 State St
Bangor, Maine 04401
(207) 973-7000
Eastern Maine Medical Center Located in Bangor, Eastern Maine Medical Center (EMMC) serves communities throughout...
?
mi
from
Bangor, ME
Click here to add this to my saved trials
Baton Rouge, Louisiana 70806
?
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Baton Rouge, Louisiana 70809
?
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Baton Rouge, Louisiana 70809
?
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
265 Fremont St
Battle Creek, Michigan 49017
(269) 245-8166
Bronson Battle Creek As a proud member of the Battle Creek community, we believe everyone...
?
mi
from
Battle Creek, MI
Click here to add this to my saved trials
Bay City, Michigan 48706
?
mi
from
Bay City, MI
Click here to add this to my saved trials
Beech Grove, Indiana 46107
?
mi
from
Beech Grove, IN
Click here to add this to my saved trials
205 Palmer Ave.
Bellefontaine, Ohio 43311
937.592.4015
Mary Rutan Hospital The hospital was endowed by the sale of a farm in Ridgeway...
?
mi
from
Bellefontaine, OH
Click here to add this to my saved trials
Bend, Oregon 97701
?
mi
from
Bend, OR
Click here to add this to my saved trials
?
mi
from
Berkeley, CA
Click here to add this to my saved trials
Bettendorf, Iowa 52722
?
mi
from
Bettendorf, IA
Click here to add this to my saved trials
?
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Big Rapids, Michigan 49307
?
mi
from
Big Rapids, MI
Click here to add this to my saved trials
?
mi
from
Billings, MT
Click here to add this to my saved trials
Billings, Montana 59101
?
mi
from
Billings, MT
Click here to add this to my saved trials
Billings, Montana 59102
?
mi
from
Billings, MT
Click here to add this to my saved trials
Billings, Montana 59101
?
mi
from
Billings, MT
Click here to add this to my saved trials
1233 North 30th Street
Billings, Montana 59101
406-237-7000
Saint Vincent Healthcare The Sisters of Charity of Leavenworth, Kansas, founded St. Vincent Healthcare in...
?
mi
from
Billings, MT
Click here to add this to my saved trials
900 E Broadway Ave
Bismarck, North Dakota 58501
(701) 530-5550
Mid Dakota Clinic, PC We're your family clinic, with the doctors you know and trust...
?
mi
from
Bismarck, ND
Click here to add this to my saved trials
900 East Broadway
Bismarck, North Dakota 58501
701.530.7000
Saint Alexius Medical Center St. Alexius Medical Center is a 306-bed, full-service, acute care medical...
?
mi
from
Bismarck, ND
Click here to add this to my saved trials
300 N. Seventh St.
Bismarck, North Dakota 58501
(701) 323-6000
Sanford Bismarck Medical Center Whether your stay in our hospital is one day for same...
?
mi
from
Bismarck, ND
Click here to add this to my saved trials
Bloomington, Illinois 61701
?
mi
from
Bloomington, IL
Click here to add this to my saved trials
1505 Eastland Drive
Bloomington, Illinois 61701
309-662-2102
Illinois CancerCare-Bloomington Illinois CancerCare, P.C. is a comprehensive practice treating patients withcancer andblood diseases. Our...
?
mi
from
Bloomington, IL
Click here to add this to my saved trials
Boca Raton, Florida 33486
?
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Bolivar, Missouri 65613
?
mi
from
Bolivar, MO
Click here to add this to my saved trials
450 Brookline Ave
Boston, Massachusetts 2215
617-632-3000
Dana-Farber Cancer Institute Since it’s founding in 1947, Dana-Farber has been committed to providing adults...
?
mi
from
Boston, MA
Click here to add this to my saved trials
1100 Balsam Ave
Boulder, Colorado 80304
(303) 440-2273
Boulder Community Hospital Founded in 1922 as a community-owned and operated not-for-profit hospital, Boulder Community...
?
mi
from
Boulder, CO
Click here to add this to my saved trials
915 Highland Blvd
Bozeman, Montana 59715
(406) 414-5000
Bozeman Deaconess Hospital Bozeman Deaconess Hospital is a Joint Commission certified, licensed Level III trauma...
?
mi
from
Bozeman, MT
Click here to add this to my saved trials
Branson, Missouri 65616
?
mi
from
Branson, MO
Click here to add this to my saved trials
?
mi
from
Bronx, NY
Click here to add this to my saved trials
?
mi
from
Bronx, NY
Click here to add this to my saved trials
?
mi
from
Bronx, NY
Click here to add this to my saved trials
130 S Bryn Mawr Ave
Bryn Mawr, Pennsylvania 19010
(484) 337-3000
Bryn Mawr Hospital Bryn Mawr Hospital, a nationally recognized community teaching hospital, is conveniently located...
?
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
?
mi
from
Burbank, CA
Click here to add this to my saved trials
1501 Trousdale Drive
Burlingame, California 94010
?
mi
from
Burlingame, CA
Click here to add this to my saved trials
Burlington, Wisconsin 53105
?
mi
from
Burlington, WI
Click here to add this to my saved trials
400 South Clark Street
Butte, Montana 59701
406-723-2500
Saint James Community Hospital and Cancer Treatment Center St. James Healthcare has played an important...
?
mi
from
Butte, MT
Click here to add this to my saved trials
?
mi
from
Camden, NJ
Click here to add this to my saved trials
210 W Walnut St
Canton, Illinois 61520
309-647-5240
Illinois CancerCare - Canton Illinois CancerCare is one of the largest private oncology and hematology...
?
mi
from
Canton, IL
Click here to add this to my saved trials
Canton, Illinois 61520
?
mi
from
Canton, IL
Click here to add this to my saved trials
2600 Sixth St. SW
Canton, Ohio 44710
330.363.4908
Aultman Health Foundation The Aultman Foundation will raise and administer funds in order to support...
?
mi
from
Canton, OH
Click here to add this to my saved trials
211 Saint Francis Drive
Cape Girardeau, Missouri 63703
573-331-3000
Saint Francis Medical Center Saint Francis Medical Center is a 282-bed facility serving more than...
?
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Cape Girardeau, Missouri 63701
?
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
789 Mt Auburn Rd
Cape Girardeau, Missouri 63703
(573) 519-4725
Southeast Cancer Center SoutheastHEALTH is a far-reaching network of providers and facilities including Southeast Hospital...
?
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
160 S Adams St
Carthage, Illinois 62321
(217) 357-6877
Illinois CancerCare - Carthage Illinois CancerCare, P.C. is a comprehensive practice treating patients withcancer andblood...
?
mi
from
Carthage, IL
Click here to add this to my saved trials
1454 North County Road 2050
Carthage, Illinois 62321
(217) 357-8500
Memorial Hospital Memorial Hospital is a vital force in establishing and maintaining the well-being of...
?
mi
from
Carthage, IL
Click here to add this to my saved trials
6501 E 2nd St
Casper, Wyoming 82609
(307) 235-5433
Rocky Mountain Oncology Rocky Mountain Oncology Center is a spacious, comfortable, state-of-the-art 19,000 square foot...
?
mi
from
Casper, WY
Click here to add this to my saved trials
20055 Lake Chabot Rd #130
Castro Valley, California 94546
(510) 888-0657
Valley Medical Oncology Consultants - Castro Valley Valley Medical Oncology Consultants (VMOC) has been helping...
?
mi
from
Castro Valley, CA
Click here to add this to my saved trials
20126 Stanton Ave
Castro Valley, California 94546
(510) 581-0556
East Bay Radiation Oncology Center East Bay Radiation Oncology Center offers superior medical and technical...
?
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Castro Valley, California 94546
?
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Centralia, Washington 98531
?
mi
from
Centralia, WA
Click here to add this to my saved trials
Chapel Hill, North Carolina 27599
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
3110 MacCorkle Avenue Southeast
Charleston, West Virginia 25304
?
mi
from
Charleston, WV
Click here to add this to my saved trials
Charlotte, North Carolina 28204
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
Charlottesville, Virginia 22901
?
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Chattanooga, Tennessee 37403
?
mi
from
Chattanooga, TN
Click here to add this to my saved trials
1969 W Ogden Ave
Chicago, Illinois 60612
(312) 864-6000
John H. Stroger, Jr. Hospital of Cook County The Level 1 Trauma Center is one...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Chicago, Illinois 60608
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Chicago, Illinois 60616
?
mi
from
Chicago, IL
Click here to add this to my saved trials